Home/Omideon/Thomas Engelen

TE

Thomas Engelen

Director

Therapeutic Areas

Omideon Pipeline

Drug	Indication	Phase
OMI-DG1	Ovarian Cancer, Colorectal Cancer	Preclinical

Leadership Team at Omideon

Dr. Graeme Rogers

Chief Scientific Officer

Douglas Thomson

View full Omideon profile